Ipratropium 500 mcg + Levosalbutamol 0.63 mg is a combination inhalation solution used for the management of respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and bronchospasm. Ipratropium works as a bronchodilator by relaxing the muscles in the airways and reducing mucus secretion, while Levosalbutamol provides fast-acting relief from bronchoconstriction by stimulating beta-2 adrenergic receptors. This combination helps in opening airways, improving breathing, and reducing shortness of breath. Formulation: Ipratropium 500 mcg + Levosalbutamol 0.63 mg per 2 mL inhalation solution.
